Here’s a story that’s eerily close to a recent experience of my own: Health Canada hands over documents but muzzles doctor Toronto doctor muzzled, not allowed to talk about morning sickness drug info Toronto Star By David Bruser and Jesse McLean Oct 14 2015 Dr. Navindra Persaud aims to publish a medical journal article based […]
I was looking at my old patent-life graph I used in a reset button…, and was updating it while I watched the debates on television. It didn’t take very long, and I found myself doodling a frequency distribution on the back of a nearby envelope. It looked kind of interesting, so I made an accurate […]
Most UK docs support disclosing payments from drug makers: survey Pharmalot by Ed Silverman October 13, 2015 To disclose or not to disclose, that is the question. A new survey of UK health providers finds that an overwhelming majority of those queried – 87 percent – believe that payments from drug makers should be transparent. […]
"Major depression is now recognized as a highly prevalent, chronic, recurrent, and disabling biological disorder with high rates of morbidity and mortality. Indeed, major depression, which is projected to be the second leading cause of disability worldwide by the year 2020, is associated with high rates of mortality secondary to suicide and to the now […]
Tom Insel came to the NIMH at the height of the rise of neuroscience. It was a new century. The future DSM-5 team was just setting its sights on finally adding the hard science fixings to the psychiatrized brain. The drugs were steadily pouring from the pharmaceutical pipeline and were hitting the top of the […]
Senator asks FTC to investigate Shkreli for antitrust violations Pharmalot by Ed Silverman October 8, 2015 A US Senator has asked the Federal Trade Commission to investigate whether drug makers are hiking prices and then restricting distribution to prevent generic drug makers from making lower-cost versions of their medicines. In a letter to the agency, […]
When Charles Schulz became Chairman of the Department of Psychiatry at the University of Minnesota Medical School in 1999, he came with a plan. I wrote about it in a series back in April if you’re not familiar with the story: Academic·Industrial·Complex I… Academic·Industrial·Complex II… Academic·Industrial·Complex III… By that time, it was a plan following […]
I haven’t followed the goings-on about the FDA appointee Dr. Robert Califf and his industry connections. I’ve been tangled up in other things. To be honest, my beefs about the FDA aren’t as strong as many who are interested in these matters. I accept that the mandate of the FDA was originally Safety and that […]
I’ve had a touch of paralysis writing this blog lately. At first I thought it had to do with our article being published [Restoring Study 329…] and the press responses that went with that [in the news…]. Then I thought maybe it had something to do with a few of the responses to the article […]